COEP
Price:
$0.2
Market Cap:
$7.99M
Coeptis Therapeutics, Inc., a biopharmaceutical company, develops and commercializes generic and branded pharmaceutical products and cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a Vy-Gen drug product for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; and CD38-Diagnostic, an in vitro screening tool to provide the ability to pre-determine which cancer patients are most likely to benefit from targeted anti-CD38 monoclonal antibodies therapies. The company has collaboration with Statera BioPharma to develop and commercialize STAT-201 for Crohn's disease; and Vici Heal...[Read more]
Industry
Biotechnology
IPO Date
2020-12-17
Stock Exchange
PNK
Ticker
COEP
According to Coeptis Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 8.22M. This represents a change of -59.26% compared to the average of 20.18M of the last 4 quarters.
The mean historical Enterprise Value of Coeptis Therapeutics, Inc. over the last ten years is 70.47M. The current 8.22M Enterprise Value has changed 1.07% with respect to the historical average. Over the past ten years (40 quarters), COEP's Enterprise Value was at its highest in in the March 2022 quarter at 207.81M. The Enterprise Value was at its lowest in in the November 2020 quarter at 11.10K.
Average
70.47M
Median
19.84M
Minimum
62.07K
Maximum
210.18M
Discovering the peaks and valleys of Coeptis Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 172.09%
Maximum Annual Enterprise Value = 210.18M
Minimum Annual Increase = -90.41%
Minimum Annual Enterprise Value = 62.07K
Year | Enterprise Value | Change |
---|---|---|
2023 | 19.89M | 0.54% |
2022 | 19.79M | -90.41% |
2021 | 206.31M | -1.84% |
2020 | 210.18M | 96.64% |
2019 | 106.89M | 172.09% |
2018 | 62.07K | -87.94% |
2005 | 514.89K | 355.41% |
The current Enterprise Value of Coeptis Therapeutics, Inc. (COEP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
82.00M
5-year avg
112.61M
10-year avg
70.47M
Coeptis Therapeutics, Inc.’s Enterprise Value is less than SeaStar Medical Holding Corporation (14.26M), greater than Virios Therapeutics, Inc. (-2813681.00), greater than ZyVersa Therapeutics, Inc. (1.84M), greater than Sonnet BioTherapeutics Holdings, Inc. (-448232.00), greater than Revelation Biosciences, Inc. (-8886223.00), greater than Clearmind Medicine Inc. (-1939881.00), greater than Hillstream BioPharma, Inc. (1.48M), greater than Magenta Therapeutics, Inc. (-114170976.00), greater than Quoin Pharmaceuticals, Ltd. (3.24M), less than Genelux Corporation (100.37M), greater than Comera Life Sciences Holdings, Inc. (-1593200.00), less than Dyadic International, Inc. (30.38M), less than Cingulate Inc. (11.61M), less than Monopar Therapeutics Inc. (81.10M), less than YS Biopharma Co., Ltd. (1.70B), greater than Allarity Therapeutics, Inc. (-15916163.00), less than Kiromic BioPharma, Inc. (10.92M), less than Aditxt, Inc. (12.23M), greater than Palisade Bio, Inc. (-7153934.00), greater than Plus Therapeutics, Inc. (6.54M),
Company | Enterprise Value | Market cap |
---|---|---|
14.26M | $12.30M | |
-2813681.00 | $206.50K | |
1.84M | $1.96M | |
-448232.00 | $2.96M | |
-8886223.00 | $3.19M | |
-1939881.00 | $5.68M | |
1.48M | $4.17M | |
-114170976.00 | $42.44M | |
3.24M | $2.86M | |
100.37M | $106.02M | |
-1593200.00 | $3.07K | |
30.38M | $30.95M | |
11.61M | $11.66M | |
81.10M | $87.22M | |
1.70B | $192.09M | |
-15916163.00 | $1.99M | |
10.92M | $1.73M | |
12.23M | $4.28M | |
-7153934.00 | $3.70M | |
6.54M | $8.02M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Coeptis Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Coeptis Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Coeptis Therapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Coeptis Therapeutics, Inc. (COEP)?
What is the 3-year average Enterprise Value for Coeptis Therapeutics, Inc. (COEP)?
What is the 5-year average Enterprise Value for Coeptis Therapeutics, Inc. (COEP)?
How does the current Enterprise Value for Coeptis Therapeutics, Inc. (COEP) compare to its historical average?